NAHRI Journal - Volume 5, Issue 3

In the balance: Weighing the benefits of self-denial and condition code 44

Wednesday, July 7, 2021
Billing and Claims, Compliance, Revenue Integrity

Gain a fresh perspective on methods to efficiently address patient status changes.Read More »

NAHRI Journal - Volume 5, Issue 3

Download the July 2021 issue of the NAHRI Journal

Wednesday, July 7, 2021
Billing and Claims, Chargemaster and Charge Capture, Coding and Documentation, Compliance, Coverage, Monitoring and Audits, Program Management, Reimbursement and Payment Methodologies, Revenue Integrity

Reach the next level of revenue integrityRead More »

NAHRI Journal - Volume 5, Issue 3

Condition code case studies

Wednesday, July 7, 2021
Billing and Claims, Compliance, Revenue Integrity

Consider these case studies to understand how to apply condition codes 44 and W2.Read More »

NAHRI Journal - Volume 5, Issue 3

Connecting the dots: Revenue integrity and utilization review

Wednesday, July 7, 2021
Billing and Claims, Compliance, Program Management, Revenue Integrity

Consider how revenue integrity and utilization review teams can work together to meet shared goals.Read More »

NAHRI Journal - Volume 5, Issue 3

Medicare prior authorization: Understanding and applying CMS updates

Wednesday, July 7, 2021
Billing and Claims, Compliance, Coverage, Revenue Integrity

Brush up on the most recent changes to Medicare’s prior authorization requirements and their operational impact.Read More »

NAHRI Journal - Volume 5, Issue 3

Keeping tabs on compliance with internal audits and monitoring

Wednesday, July 7, 2021
Billing and Claims, Chargemaster and Charge Capture, Coding and Documentation, Compliance, Monitoring and Audits, Revenue Integrity

Learn how to use regular internal audits and monitoring to boost compliance in revenue integrity areas.Read More »

Leadership Council Insider

CMS increases at-home COVID-19 vaccine payment rate, HHS issues billing reminder

Friday, June 18, 2021
Billing and Claims, NAHRI Leadership Council, Reimbursement and Payment Methodologies, Revenue Integrity

CMS announced an increase in Medicare payment for at-home administration of COVID-19 vaccines. Medicare will now pay $75 per at-home dose, nearly double its previous $40 adminitration rate.Read More »

Revenue Integrity Insider

CMS raises some COVID-19 vaccine payments as HHS issues reminder of billing rules

Wednesday, June 16, 2021
Billing and Claims, Compliance, Coverage, Reimbursement and Payment Methodologies, Revenue Integrity

CMS boosted Medicare payment for COVID-19 vaccines administered in the patient’s home to $75 per dose, the agency announced June 9. Prior to June 9, Medicare paid $40 per dose for COVID-19 vaccines administered in the patient’s home.Read More »

Pages